Aida Pharmaceuticals, Inc.
AIDA · OTC
9/30/2008 | 6/30/2008 | 3/31/2008 | 12/31/2007 | |
|---|---|---|---|---|
| Market Cap | $12,717 | $22,140 | $31,320 | $30,510 |
| - Cash | $8,278 | $4,235 | $4,597 | $8,399 |
| + Debt | $41,160 | $36,677 | $37,401 | $33,368 |
| Enterprise Value | $45,598 | $54,582 | $64,124 | $55,479 |
| Revenue | $11,885 | $10,900 | $7,652 | $10,517 |
| % Growth | 9% | 42.4% | -27.2% | – |
| Gross Profit | $6,927 | $6,168 | $3,952 | $5,747 |
| % Margin | 58.3% | 56.6% | 51.6% | 54.6% |
| EBITDA | $3,356 | -$5,791 | $1,186 | $3,722 |
| % Margin | 28.2% | -53.1% | 15.5% | 35.4% |
| Net Income | $2,290 | -$6,771 | -$19 | $2,406 |
| % Margin | 19.3% | -62.1% | -0.2% | 22.9% |
| EPS Diluted | 0.08 | -0.25 | -0.001 | 0.09 |
| % Growth | 132% | -35,614.3% | -100.8% | – |
| Operating Cash Flow | $2,148 | $1,524 | $611 | $1,885 |
| Capital Expenditures | -$2,552 | -$767 | -$457 | -$1,482 |
| Free Cash Flow | -$404 | $757 | $155 | $403 |